BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 6878384)

  • 1. The physiologic effects of oxygen transport by hemoglobin solutions.
    Moores WY; White FC; Bloor C; Greenburg AG; Mack R; Willford DC
    Prog Clin Biol Res; 1983; 122():89-99. PubMed ID: 6878384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extending the limits of hemodilution on cardiopulmonary bypass using stroma-free hemoglobin solution.
    Moores WY; De Venuto F; Heydorn WH; Weiskopf RB; Baysinger M; Greenburg AG; Utley JR
    J Thorac Cardiovasc Surg; 1981 Feb; 81(2):155-62. PubMed ID: 7453225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic effects and oxygen transport properties of a new blood substitute in a model of massive blood replacement.
    Vlahakes GJ; Lee R; Jacobs EE; LaRaia PJ; Austen WG
    J Thorac Cardiovasc Surg; 1990 Sep; 100(3):379-88. PubMed ID: 2391974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional blood flow after serial normovolemic exchange transfusion with HBOC-201 (Hemopure) in anesthetized swine.
    Mongan PD; Moon-Massat PF; Rentko V; Mihok S; Dragovich A; Sharma P
    J Trauma; 2009 Jul; 67(1):51-60. PubMed ID: 19590308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histology and ultrastructure of liver and kidney following blood exchange with ultrapurified, polymerised bovine hemoglobin in comparison with hydroxyethyl starch.
    Lipfert B; Standl T; Düllmann J; Helmchen U; Schulte am Esch J; Lorke DE
    Lab Invest; 1999 May; 79(5):573-82. PubMed ID: 10334568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive properties of synthetic blood substitutes.
    de Figueiredo LF
    Medicina (B Aires); 1998; 58(4):403-10. PubMed ID: 9816703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Animal experiment studies on hemodynamics following partial and total blood exchange with a pyridoxalated polyhemoglobin solution].
    Hobbhahn J; Jesch F; Conzen P; Brendel W; Peter K
    Anaesthesist; 1985 Aug; 34(8):396-401. PubMed ID: 3931496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the acute hemodynamic and delayed effects of 50% exchange transfusion with two different cross-linked hemoglobin based oxygen carrying solutions and Pentastarch.
    Bonegio RG; Fuhro R; Ragno G; Robert Valeri C; Lieberthal W
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(2):145-57. PubMed ID: 16537171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of efficacy of stroma free hemoglobin solutions.
    Rosen AL; Gould SA; Sehgal LR; Sehgal HL; Moss GS
    Prog Clin Biol Res; 1983; 122():79-88. PubMed ID: 6878383
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of stroma-free hemoglobin solution on oxygen consumption in some tissues].
    Schier J; Kluciński W; Sitarska E; Daszyński J; Rudowski W; Mośoicka M; Kostrzewska E
    Acta Haematol Pol; 1975; 6(3):201-10. PubMed ID: 1163185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemoglobin solution: a potential oxygen transporting plasma volume expander.
    Kaplan HR; Murthy VS
    Fed Proc; 1975 May; 34(6):1461-5. PubMed ID: 1126443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphologic effects following massive exchange transfusions with a stroma-free hemoglobin solution. II. Kidney.
    Friedman H; DeVenuto F; Lollini L; Mellick P; Zuck TF
    Lab Invest; 1979 Jun; 40(6):655-67. PubMed ID: 449274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphologic effects following massive exchange transfusions with a stroma-free hemoglobin solution. I. Liver.
    Friedman HI; DeVenuto F; Lollini L; Mellick P; Zuck TF
    Lab Invest; 1978 Aug; 39(2):167-77. PubMed ID: 682601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a modified, stroma-free hemoglobin solution as an oxygen-carrying plasma substitute.
    Kothe N; Eichentopf B; Bonhard K
    Surg Gynecol Obstet; 1985 Dec; 161(6):563-9. PubMed ID: 4071369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bovine polymerized hemoglobin (hemoglobin-based oxygen carrier-201) resuscitation in three swine models of hemorrhagic shock with militarily relevant delayed evacuation--effects on histopathology and organ function.
    Johnson T; Arnaud F; Dong F; Philbin N; Rice J; Asher L; Arrisueno M; Warndorf M; Gurney J; McGwin G; Kaplan L; Flournoy WS; Apple FS; Pearce LB; Ahlers S; McCarron R; Freilich D
    Crit Care Med; 2006 May; 34(5):1464-74. PubMed ID: 16540964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the hemoglobin-based oxygen carrier HBOC-201 to other low-volume resuscitation fluids in a model of controlled hemorrhagic shock.
    Sampson JB; Davis MR; Mueller DL; Kashyap VS; Jenkins DH; Kerby JD
    J Trauma; 2003 Oct; 55(4):747-54. PubMed ID: 14566133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of stroma-free hemoglobin solutions as blood substitute].
    Birkigt HG; Heinrich P; Brandstädter W; Fritzsche L
    Z Exp Chir; 1980; 13(4):230-4. PubMed ID: 7415348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of stroma-free hemoglobin solutions in hemorrhagic shock--a review of animal experimental results].
    Birkigt HG
    Z Exp Chir Transplant Kunstliche Organe; 1983; 16(2):103-8. PubMed ID: 6868726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymerized pyridoxylated hemoglobin: a red cell substitute with normal oxygen capacity.
    Sehgal LR; Gould SA; Rosen AL; Sehgal HL; Moss GS
    Surgery; 1984 Apr; 95(4):433-8. PubMed ID: 6710339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.